( Log in to your Wikimedia account to use OAuth instead of Quickstatements for updates.)
Author name:
Limit:
Additional SPARQL filters separated by semicolons (eg. for papers on Zika virus, enter wdt:P921 wd:Q202864):
Filter potential authors as well?

Potential publications

23 publications found

Click here to create clusters based on exact author strings rather than rougher matches.

Group #1

Matched potential author: Mikko Siurala - author of 1 items
TitleAuthors (identified)Published InIdentifier(s)TopicPublished DateMatch?
Potentiating adoptive cell therapy using synthetic IL-9 receptors[1]Anusha Kalbasi, [2]Mikko Siurala, [3]Leon L. Su, [4]Mito Tariveranmoshabad, [5]Lora K. Picton, [6]Pranali Ravikumar, [7]Peng Li, [8]Jian-Xin Lin, [9]Helena Escuin-Ordinas, [10]Tong Da, ... [Full author list]Nature [missing]DOI: 10.1038/S41586-022-04801-2 [ORCID]
PubMed: 35676488 [ORCID]
2022-06-08
Tumor microenvironment remodeling by an engineered oncolytic adenovirus results in improved outcome from PD-L1 inhibition[1]Victor Cervera-Carrascon, [2]Dafne C A Quixabeira, [3]Joao Manuel Santos, [4]Riikka Havunen, [5]Sadia Zafar, [6]Otto Hemminki, [7]Camilla Heiniö, [8]Eleonora Munaro, [9]Mikko Siurala, [10]Suvi Sorsa, [11]Tuomas Mirtti, [12]Petrus Järvinen, [13]Markus Mildh, [14]Harry Nisen, [15]Antti Rannikko, [16]Marjukka Anttila, [17]Anna Kanerva, [18]Akseli Hemminki [Full author list]OncoImmunology [missing]DOI: 10.1080/2162402X.2020.1761229 [ORCID]
PubMed: 32923123 [ORCID]
2020-05-22
Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors[1]Victor Cervera-Carrascon, [2]Dafne C A Quixabeira, [3]Riikka Havunen, [4]Joao M Santos, [5]Emma Kutvonen, [6]James H A Clubb, [7]Mikko Siurala, [8]Camilla Heiniö, [9]Sadia Zafar, [10]Teija Koivula, [11]Dave Lumen, [12]Marjo Vaha, [13]Arturo Garcia-Horsman, [14]Anu J Airaksinen, [15]Suvi Sorsa, [16]Marjukka Anttila, [17]Veijo Hukkanen, [18]Anna Kanerva, [19]Akseli Hemminki [Full author list]Molecular therapy oncolytics [missing]DOI: 10.1016/J.OMTO.2020.03.003 [ORCID]
PubMed: 32322662 [ORCID]
2020-03-19
Oncolytic adenovirus shapes the ovarian tumor microenvironment for potent tumor-infiltrating lymphocyte tumor reactivity[1]João Manuel Santos, [2]Camilla Heiniö, [3]Victor Cervera-Carrascon, [4]Dafne C A Quixabeira, [5]Mikko Siurala, [6]Riikka Havunen, [7]Ralf Butzow, [8]Sadia Zafar, [9]Tanja D de Gruijl, [10]Heini Lassus, [11]Anna Kanerva, [12]Akseli Hemminki [Full author list]Journal for Immunotherapy of Cancer [missing]DOI: 10.1136/JITC-2019-000188 [ORCID]
PubMed: 31940588 [ORCID]
2020-01-01Mikko Siurala (Q114523080; 1 items)
Effect of Genetic Modifications on Physical and Functional Titers of Adenoviral Cancer Gene Therapy Constructs[1]Camilla Heiniö, [2]Suvi Sorsa, [3]Mikko Siurala, [4]Susanna Grönberg-Vähä-Koskela, [5]Riikka Havunen, [6]Elina Haavisto, [7]Anniina Koski, [8]Otto Hemminki, [9]Sadia Zafar, [10]Victor Cervera-Carrascon, [11]Eleonora Munaro, [12]Anna Kanerva, [13]Akseli Hemminki [Full author list]Human Gene Therapy [missing]DOI: 10.1089/HUM.2018.240 [ORCID]
PubMed: 30672366 [ORCID]
Adenoviridae [missing]; oncolytic virus [missing]; cancer gene therapy [missing]2019-02-28
Abscopal Effect in Non-injected Tumors Achieved with Cytokine-Armed Oncolytic Adenovirus[1]Riikka Havunen, [2]João M Santos, [3]Suvi Sorsa, [4]Tommi Rantapero, [5]Dave Lumen, [6]Mikko Siurala, [7]Anu J Airaksinen, [8]Victor Cervera-Carrascon, [9]Siri Tähtinen, [10]Anna Kanerva, [11]Akseli Hemminki [Full author list]Molecular therapy oncolytics [missing]DOI: 10.1016/J.OMTO.2018.10.005 [ORCID]
PubMed: 30569015 [ORCID]
immunotherapy [missing]; oncolytic virus [missing]; abscopal effect [missing]2018-12-21Mikko Siurala (Q114523080; 1 items)
Adenovirus Coding for Interleukin-2 and Tumor Necrosis Factor Alpha Replaces Lymphodepleting Chemotherapy in Adoptive T Cell Therapy[1]João Manuel Santos, [2]Víctor Cervera-Carrascon, [3]Riikka Havunen, [4]Sadia Zafar, [5]Mikko Siurala, [6]Suvi Sorsa, [7]Marjukka Anttila, [8]Anna Kanerva, [9]Akseli Hemminki [Full author list]Molecular Therapy [missing]DOI: 10.1016/J.YMTHE.2018.06.001 [ORCID]
PubMed: 30017877 [ORCID]
molecular biology [missing]; Adenoviridae [missing]; interleukins [missing]; chemotherapy [missing]; drug discovery [missing]; molecular medicine [missing]2018-09-05Mikko Siurala (Q114523080; 1 items)
Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses.[1]Keisuke Watanabe, [2]Yanping Luo, [3]Tong Da, [4]Sonia Guedan, [5]Marco Ruella, [6]John Scholler, [7]Brian Keith, [8]Regina M Young, [9]Boris Engels, [10]Suvi Sorsa, [11]Mikko Siurala, [12]Riikka Havunen, [13]Siri Tähtinen, [14]Akseli Hemminki, [15]Carl H. June [Full author list]JCI insight [missing]DOI: 10.1172/JCI.INSIGHT.99573 [ORCID]
PubMed: 29618658 [ORCID]
Adenoviridae [missing]; pancreatic cancer [missing]; oncolytic virus [missing]2018-04-05Mikko Siurala (Q114523080; 1 items)
CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapy[1]Sadia Zafar, [2]Suvi Sorsa, [3]Mikko Siurala, [4]Otto Hemminki, [5]Riikka Havunen, [6]Victor Cervera-Carrascon, [7]João Manuel Santos, [8]Hongjie Wang, [9]Andre Lieber, [10]Tanja D de Gruijl, [11]Anna Kanerva, [12]Akseli Hemminki [Full author list]OncoImmunology [missing]DOI: 10.1080/2162402X.2018.1490856 [ORCID]
PubMed: 30386680 [ORCID]
immunology [missing]; Adenoviridae [missing]; dendritic cell [missing]; oncolytic virus [missing]2018-01-01Mikko Siurala (Q114523080; 1 items)
Adenoviral production of interleukin-2 at the tumor site removes the need for systemic postconditioning in adoptive cell therapy[1]Joao Manuel Santos, [2]Riikka Havunen, [3]Mikko Siurala, [4]Víctor Cervera-Carrascon, [5]Siri Tähtinen, [6]Suvi Sorsa, [7]Marjukka Anttila, [8]Pauliina Karell, [9]Anna Kanerva, [10]Akseli Hemminki [Full author list]International Journal of Cancer [missing]DOI: 10.1002/IJC.30839 [ORCID]
PubMed: 28614908 [ORCID]
Adenoviridae [missing]2017-06-14Mikko Siurala (Q114523080; 1 items)
Oncolytic Adenoviruses Armed with Tumor Necrosis Factor Alpha and Interleukin-2 Enable Successful Adoptive Cell Therapy[1]Riikka Havunen, [2]Mikko Siurala, [3]Suvi Sorsa, [4]Susanna Grönberg-Vähä-Koskela, [5]Michael Behr, [6]Siri Tähtinen, [7]João Manuel Santos, [8]Pauliina Karell, [9]Juuso Rusanen, [10]Dirk M Nettelbeck, [11]Anja Ehrhardt, [12]Anna Kanerva, [13]Akseli Hemminki [Full author list]Molecular therapy oncolytics [missing]DOI: 10.1016/J.OMTO.2016.12.004 [ORCID]
PubMed: 28345026 [ORCID]
Adenoviridae [missing]; interleukins [missing]; oncolytic virus [missing]2016-12-31Mikko Siurala (Q114523080; 1 items)
Intravenously usable fully serotype 3 oncolytic adenovirus coding for CD40L as an enabler of dendritic cell therapy[1]Sadia Zafar, [2]Suvi Parviainen, [3]Mikko Siurala, [4]Otto Hemminki, [5]Riikka Havunen, [6]Siri Tähtinen, [7]Simona Bramante, [8]Lotta Vassilev, [9]Hongjie Wang, [10]Andre Lieber, [11]Silvio Hemmi, [12]Tanja D de Gruijl, [13]Anna Kanerva, [14]Akseli Hemminki [Full author list]OncoImmunology [missing]DOI: 10.1080/2162402X.2016.1265717 [ORCID]
PubMed: 28344872 [ORCID]
Adenoviridae [missing]; usability [missing]; dendritic cell [missing]; oncolytic virus [missing]2016-12-07Mikko Siurala (Q114523080; 1 items)
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016.[1]Casey R Ager, [2]Matthew Reilley, [3]Courtney Nicholas, [4]Todd Bartkowiak, [5]Ashvin R Jaiswal, [6]Michael A. Curran, [7]Tina C. Albershardt, [8]Anshika Bajaj, [9]Jacob F. Archer, [10]Rebecca S. Reeves, ..., [94]Yama Abassi, [95]Victor Cervera-Carrascon, [96]Mikko Siurala, [97]João Santos, [98]Riikka Havunen, ..., [1060]Sadia Zafar, [1061]Suvi Parviainen, [1062]Mikko Siurala, [1063]Otto Hemminki, [1064]Riikka Havunen, ... [Full author list]Journal for Immunotherapy of Cancer [missing]DOI: 10.1186/S40425-016-0173-6 [ORCID]
immunotherapy [missing]2016-11-16Mikko Siurala (Q114523080; 1 items)
T-Cell Therapy Enabling Adenoviruses Coding for IL2 and TNFα Induce Systemic Immunomodulation in Mice With Spontaneous Melanoma[1]Siri Tähtinen, [2]Carolin Blattner, [3]Markus Vähä-Koskela, [4]Dipongkor Saha, [5]Mikko Siurala, [6]Suvi Parviainen, [7]Jochen Utikal, [8]Anna Kanerva, [9]Viktor Umansky, [10]Akseli Hemminki [Full author list]Journal of Immunotherapy [missing]DOI: 10.1097/CJI.0000000000000144 [ORCID]
PubMed: 27741089 [ORCID]
Adenoviridae [missing]2016-11-01Mikko Siurala (Q114523080; 1 items)
Corrigendum to "Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma".[1]Mikko Siurala, [2]Riikka Havunen, [3]Dipongkor Saha, [4]Dave Lumen, [5]Anu J Airaksinen, [6]Siri Tähtinen, [7]Víctor Cervera-Carrascon, [8]Simona Bramante, [9]Suvi Parviainen, [10]Markus Vähä-Koskela, [11]Anna Kanerva, [12]Akseli Hemminki [Full author list]Molecular Therapy [missing]DOI: 10.1038/MT.2016.196 [ORCID]
PubMed: 27916990 [ORCID]
Adenoviridae [missing]2016-11-01Mikko Siurala (Q114523080; 1 items)
Adenoviral Delivery of Tumor Necrosis Factor-α and Interleukin-2 Enables Successful Adoptive Cell Therapy of Immunosuppressive Melanoma[1]Mikko Siurala, [2]Riikka Havunen, [3]Dipongkor Saha, [4]Dave Lumen, [5]Anu J Airaksinen, [6]Siri Tähtinen, [7]Víctor Cervera-Carrascon, [8]Simona Bramante, [9]Suvi Parviainen, [10]Markus Vähä-Koskela, [11]Anna Kanerva, [12]Akseli Hemminki [Full author list]Molecular Therapy [missing]DOI: 10.1038/MT.2016.137 [ORCID]
PubMed: 27357626 [ORCID]
Adenoviridae [missing]2016-06-30Mikko Siurala (Q114523080; 1 items)
Syngeneic syrian hamster tumors feature tumor-infiltrating lymphocytes allowing adoptive cell therapy enhanced by oncolytic adenovirus in a replication permissive setting[1]Mikko Siurala, [2]Markus Vähä-Koskela, [3]Riikka Havunen, [4]Siri Tähtinen, [5]Simona Bramante, [6]Suvi Parviainen, [7]J Michael Mathis, [8]Anna Kanerva, [9]Akseli Hemminki [Full author list]OncoImmunology [missing]DOI: 10.1080/2162402X.2015.1136046 [ORCID]
PubMed: 27467954 [ORCID]
Adenoviridae [missing]; Syrian hamster [missing]; oncolytic virus [missing]2016-02-18Mikko Siurala (Q114523080; 1 items)
Improving adoptive T cell therapy with adenoviruse armed with TNF-α and IL-2.[1]Riikka Havunen, [2]Mikko Siurala, [3]Suvi Parviainen, [4]Simona Bramante, [5]Dipongor Saha, [6]Siri Tähtinen, [7]Markus Vähä-Koskela, [8]Michael Behr, [9]Dirk Nettelbeck, [10]Anja Ehrhardt, [11]Akseli Hemminki [Full author list]Journal for Immunotherapy of Cancer [missing]DOI: 10.1186/2051-1426-3-S2-P41 [ORCID]
2015-11-04Mikko Siurala (Q114523080; 1 items)
Oncolytic adenovirus improves anti-tumor efficacy of adoptive T cell therapy by breaking tumor-induced immunosuppression and peripheral tolerance.[1]Siri Tähtinen, [2]Susanna Grönberg-Vähä-Koskela, [3]Dave Lumen, [4]Maiju Merisalo-Soikkeli, [5]Mikko Siurala, [6]Anu J Airaksinen, [7]Markus Vähä-Koskela, [8]Akseli Hemminki [Full author list]Journal for Immunotherapy of Cancer [missing]DOI: 10.1186/2051-1426-3-S2-P315 [ORCID]
Adenoviridae [missing]; immunosuppression [missing]; oncolytic virus [missing]2015-11-04Mikko Siurala (Q114523080; 1 items)
Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer[1]Simona Bramante, [2]Anniina Koski, [3]Ilkka Liikanen, [4]Lotta Vassilev, [5]Minna Oksanen, [6]Mikko Siurala, [7]Raita Heiskanen, [8]Tiina Hakonen, [9]Timo Joensuu, [10]Anna Kanerva, [11]Sari Pesonen, [12]Akseli Hemminki [Full author list]OncoImmunology [missing]DOI: 10.1080/2162402X.2015.1078057 [ORCID]
PubMed: 27057453 [ORCID]
breast cancer [missing]; oncolytic virus [missing]2015-08-27Mikko Siurala (Q114523080; 1 items)
Adenovirus Improves the Efficacy of Adoptive T-cell Therapy by Recruiting Immune Cells to and Promoting Their Activity at the Tumor[1]Siri Tähtinen, [2]Susanna Grönberg-Vähä-Koskela, [3]Dave Lumen, [4]Maiju Merisalo-Soikkeli, [5]Mikko Siurala, [6]Anu J Airaksinen, [7]Markus Vähä-Koskela, [8]Akseli Hemminki [Full author list]Cancer Immunology Research [missing]DOI: 10.1158/2326-6066.CIR-14-0220-T [ORCID]
PubMed: 25977260 [ORCID]
Adenoviridae [missing]2015-05-14Mikko Siurala (Q114523080; 1 items)
GMCSF-armed vaccinia virus induces an antitumor immune response[1]Suvi Parviainen, [2]Marko Ahonen, [3]Iulia Diaconu, [4]Anja Kipar, [5]Mikko Siurala, [6]Markus Vähä-Koskela, [7]Anna Kanerva, [8]Vincenzo Cerullo, [9]Akseli Hemminki [Full author list]International Journal of Cancer [missing]DOI: 10.1002/IJC.29068 [ORCID]
PubMed: 25042001 [ORCID]
Vaccinia virus [missing]2014-07-10Mikko Siurala (Q114523080; 1 items)
Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma[1]Mikko Siurala, [2]Simona Bramante, [3]Lotta Vassilev, [4]Mari Hirvinen, [5]Suvi Parviainen, [6]Siri Tähtinen, [7]Kilian Guse, [8]Vincenzo Cerullo, [9]Anna Kanerva, [10]Anja Kipar, [11]Markus Vähä-Koskela, [12]Akseli Hemminki [Full author list]International Journal of Cancer [missing]DOI: 10.1002/IJC.29048 [ORCID]
PubMed: 24975392 [ORCID]
Adenoviridae [missing]; chemotherapy [missing]; oncolytic virus [missing]2014-07-03Mikko Siurala (Q114523080; 1 items)

Potential author items

NameDescriptionAuthored itemsIdentifiersEmployer(s)
Mikko Siuralaresearcher1
Other Q number of this author

New Author Item

(if the author you are looking for is not listed above and otherwise not yet in Wikidata)
Author name:
Check ORCID for Mikko Siurala | Author has ORCID ID:
Check VIAF for Mikko Siurala | Author has VIAF ID:
Check ResearchGate for Mikko Siurala | Author has ResearchGate Profile ID:
After creating the new author item, enter the Wikidata ID in the "Other Q number of this author" field above to link to their works.

Author items in these papers

Common author name strings in these papers

Publishing venues for these papers

Topics for these papers

Feedback
Source and documentation (at github)
Wikidata page